Y

YMAB

Y-Mabs Therapeutics

4.20

-0.03-0.71%
After Hours: 4.041  -0.16  -3.79%16:26 04/29 EDT

Financial Statements

Statement:

Key indicator

Income Statement

Balance Sheet

Cash Flow

Reporting Period:

Accumulated Report

FY

YoY:
FY: Financial Year Annual Report
Q: Quarter is quarterly reports. Q1, Q2, Q3 and Q4 are reports for a single quarter. Q6 and Q9 are accumulated quarterly reports, respectively contain 6 months' reports and 9 months' report.
Item
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Total Assets

119.90M

127.87M

141.46M

212.78M

132.05M

Total Current Assets

98.51M

111.11M

130.45M

202.26M

122.36M

Total Non Current Assets

21.39M

16.76M

11.01M

10.52M

9.68M

Total Liabilities

27.90M

26.88M

32.23M

32.68M

26.21M

Total Current Liabilities

23.70M

20.13M

28.28M

27.88M

19.54M

Total Non Current Liabilities

4.20M

6.76M

3.95M

4.80M

6.68M

Total Equity

92.00M

100.98M

109.22M

180.11M

105.84M

Total Stockholders Equity

92.00M

100.98M

109.22M

180.11M

105.84M

Minority Interest

--

--

--

--

--

Total Liabilities & Shareholders Equity

119.90M

127.87M

141.46M

212.78M

132.05M

Total Common Shares Outstanding

44.99M

43.67M

43.67M

43.69M

40.69M

Total Preferred Shares Outstanding

--

--

--

--

--